Legal & General Group’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$801K Buy
44,235
+11,106
+34% +$201K ﹤0.01% 2298
2025
Q1
$678K Buy
33,129
+10,183
+44% +$208K ﹤0.01% 2307
2024
Q4
$590K Buy
22,946
+7,110
+45% +$183K ﹤0.01% 2402
2024
Q3
$263K Hold
15,836
﹤0.01% 2631
2024
Q2
$304K Buy
+15,836
New +$304K ﹤0.01% 2598